相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。The High-Affinity CXCR4 Antagonist BKT140 Is Safe and Induces a Robust Mobilization of Human CD34+ Cells in Patients with Multiple Myeloma
Amnon Peled et al.
CLINICAL CANCER RESEARCH (2014)
CXCR4 drives the metastatic phenotype in breast cancer through induction of CXCR2 and activation of MEK and PI3K pathways
Tammy Sobolik et al.
MOLECULAR BIOLOGY OF THE CELL (2014)
A review on CXCR4/CXCL12 axis in oncology: No place to hide
Urszula M. Domanska et al.
EUROPEAN JOURNAL OF CANCER (2013)
Mobilization of hematopoietic stem and progenitor cells using inhibitors of CXCR4 and VLA-4
M. P. Rettig et al.
LEUKEMIA (2012)
Synthesis of site-specific antibody-drug conjugates using unnatural amino acids
Jun Y. Axup et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
AMD3100 is a potent antagonist at CXCR4R334X, a hyperfunctional mutant chemokine receptor and cause of WHIM syndrome
David H. McDermott et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2011)
AMD3100 sensitizes acute lymphoblastic leukemia cells to chemotherapy in vivo
M. Yu et al.
BLOOD CANCER JOURNAL (2011)
CXCL12/CXCR4/CXCR7 chemokine axis and cancer progression
Xueqing Sun et al.
CANCER AND METASTASIS REVIEWS (2010)
CXCR4 Signaling Regulates Metastasis of Chemoresistant Melanoma Cells by a Lymphatic Metastatic Niche
Minah Kim et al.
CANCER RESEARCH (2010)
Intracellular Activation of SGN-35, a Potent Anti-CD30 Antibody-Drug Conjugate
Nicole M. Okeley et al.
CLINICAL CANCER RESEARCH (2010)
Potent antibody drug conjugates for cancer therapy
Peter D. Senter
CURRENT OPINION IN CHEMICAL BIOLOGY (2009)
Mouse Hematopoietic Stem Cell Identification and Analysis
Grant A. Challen et al.
CYTOMETRY PART A (2009)
CXCR4 Regulates the Early Extravasation of Metastatic Tumor Cells In Vivo
Peter Gassmann et al.
NEOPLASIA (2009)
A Human Antibody-Drug Conjugate Targeting EphA2 Inhibits Tumor Growth In vivo
Dowdy Jackson et al.
CANCER RESEARCH (2008)
The critical role of SDF-1/CXCR4 axis in cancer and cancer stem cells metastasis
S. Gellmini et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2008)
Cell killing by antibody-drug conjugates
Yelena V. Kovtun et al.
CANCER LETTERS (2007)
Potent antitumor activity of an auristatin-conjugated, fully human monoclonal antibody to prostate-specific membrane antigen
DS Ma et al.
CLINICAL CANCER RESEARCH (2006)
Lysosomal trafficking and cysteine protease metabolism confer target-specific cytotoxicity by peptide-linked anti-CD30-auristatin conjugates
MSK Sutherland et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Bone-marrow haematopoietic-stem-cell niches
A Wilson et al.
NATURE REVIEWS IMMUNOLOGY (2006)
CXCR4 regulates migration and development of human acute myelogenous leukemia stem cells in transplanted NOD/SCID mice
S Tavor et al.
CANCER RESEARCH (2004)
T140 analogs as CXCR4 antagonists identified as anti-metastatic agents in the treatment of breast cancer
H Tamamura et al.
FEBS LETTERS (2003)
cAC10-vcMMAE, an anti-CD30-monomethyl auristatin E conjugate with potent and selective antitumor activity
JA Francisco et al.
BLOOD (2003)
Development of potent monoclonal antibody auristatin conjugates for cancer therapy
SO Doronina et al.
NATURE BIOTECHNOLOGY (2003)
Role of the intracellular domains of CXCR4 in SDF-1-mediated signaling
J Roland et al.
BLOOD (2003)
CXCR4-SDF-1 signaling is active in rhabdomyosarcoma cells and regulates locomotion, chemotaxis, and adhesion
J Libura et al.
BLOOD (2002)
The human hematopoietic stem cell compartment is heterogeneous for CXCR4 expression
M Rosu-Myles et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)